FreshAir, an industry leader in the development of sensors to detect and alert for hazardous chemicals, announces that it has been awarded a Fast-Track Phase II grant totaling over $1.2 million from the National Institute on Drug Abuse, part of the National Institutes of Health. The eighteen-month grant follows FreshAir’s successful completion of milestones for the Fast-Track Phase I grant received in September 2019 and will support development of effective vaping sensors for use in schools and other environments.
“We are accelerating the development of our sensors specific to the molecules released during e-cigarette vaping,” said Joseph BelBruno, Chief Technology Officer of FreshAir.
FreshAir already offers the market’s only technology to monitor for, immediately detect, and scientifically prove tobacco smoking and marijuana smoking. The company is continuing to improve upon its patented PolySens® polymer sensor technology in order to detect and prove e-cigarette vaping.
“Our mission as a company is to ‘improve lives through novel sensor technology,’ and our objectives with this grant are to help schools reduce the incidence of vaping and improve youth health outcomes,” BelBruno added.
For more information on FreshAir, please visit: https://www.freshairsensor.com/.
About FreshAir
FreshAir has the only technology available to monitor for, immediately detect, and prove tobacco smoking and marijuana smoking. Based on 17 years of research and development, the company’s PolySens® patented polymer sensor technology immediately detects specific molecules in tobacco smoke and marijuana smoke.
FreshAir’s mission is to improve lives through novel sensor technology. The company’s chemistry and engineering teams have an active research and development agenda to expand the application of existing sensors and develop new sensors for other hazardous chemicals.
Research reported in this publication was supported by the National Institute on Drug Abuse part of the National Institutes of Health under Award Number R44DA049595. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
The 2024 virtual Men’s Round Table will be held Q4, 2024, date TBD.
